Trial Profile
Clinical Protocol for a Double-Blind, Placebo-Controlled, Randomized Dose-Ranging Study of Celecoxib (SC-58635) on the Acute Effect of Human UV-Irradiation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary)
- Indications Skin cancer; Sunburn
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 18 Jun 2014 New trial record